Cutler Group’s Array Biopharma Inc ARRY Stock Holding History

Cutler Group’s Portfolio ARRY Stock Details ARRY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-65,300	Closed	-$1.15M	–	5059
2019 Q2	$1.15M	Sell	65,300 -44,900	-41%	-$1.26M	0.11%	163
2019 Q1	$448K	Buy	110,200 +101,700	+1,196%	+$2.12M	0.05%	345
2018 Q4	$5K	Hold	8,500	–	–	﹤0.01%	2980
2018 Q3	$15K	Sell	8,500 -500	-6%	-$7.66K	﹤0.01%	2437
2018 Q2	$33K	Sell	9,000 -22,000	-71%	-$350K	﹤0.01%	1871
2018 Q1	$107K	Buy	31,000 +19,200	+163%	+$308K	0.01%	1135
2017 Q4	$30K	Sell	11,800 -35,500	-75%	-$404K	﹤0.01%	2252
2017 Q3	$84K	Buy	47,300 +5,500	+13%	+$51.1K	﹤0.01%	1810
2017 Q2	$15K	Buy	41,800 +2,000	+5%	+$16.4K	﹤0.01%	3763
2017 Q1	$20K	Buy	39,800 +12,200	+44%	+$130K	﹤0.01%	3349
2016 Q4	$53K	Sell	27,600 -2,700	-9%	-$19.9K	﹤0.01%	2485
2016 Q3	$54K	Buy	+30,300	New	+$117K	﹤0.01%	2400
2016 Q2	–	Sell	-134,800	Closed	-$23K	–	7646
2016 Q1	$23K	Buy	+134,800	New	+$404K	﹤0.01%	3152

Other funds holding ARRY

ASN

Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

Cutler Group's ARRY Position: Q1 2019 in Review

Cutler Group sold out of Array Biopharma Inc (ARRY) in Q1 2019, closing a stake of 1,500 shares — an estimated $31.2K sold.

Cutler Group first reported a position in ARRY in Q4 2015 and held it in 13 quarters. The position peaked at $539K in Q1 2017. 268 funds tracked by Wall St. Rank hold ARRY as of Q1 2019.

Cutler Group reported no remaining Array Biopharma Inc position as of Q1 2019 after selling out during the quarter.
Cutler Group sold 1,500 Array Biopharma Inc shares in Q1 2019, an estimated $31.2K.
Cutler Group first reported a position in Array Biopharma Inc in Q4 2015 and held it in 13 quarters.
Cutler Group's Array Biopharma Inc position peaked at $539K in Q1 2017.
268 funds tracked by Wall St. Rank held Array Biopharma Inc as of Q1 2019.

Based on Cutler Group's 13F filing for Q1 2019, filed 10 May 2019.